ZGZuzanna Gąsior

Zuzanna Gąsior

*This is an algorithmically generated author record based on publicly available information.

Zuzanna Gąsior has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • COMBINING SGLT2 INHIBITORS AND FINERENONE IN CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME: A CLINICAL UPDATE

    by Przemysław Krukowski, Zuzanna Gąsior, Maria Grabowska, Michał Stermach, Michał Maciejowski, Mateusz Zdaniewicz, Zuzanna Lecyk, Agata Leszek, Kacper Ćwiek, Adrianna Przedborska

    Background Patients with chronic kidney disease (CKD), particularly those with type 2 diabetes (T2D) and albuminuria, remain at substantial risk of kidney disease progression and cardiovascular complications despite established therapy. SGLT2 inhibitors and finerenone act through distinct and potentially complementary mechanisms. Aims To evaluate the mechanisms, clinical effects, and safety of combined SGLT2 inhibitor and finerenone therapy in patients with CKD, particularly those with T2D and albuminuria, and to consider these findings within the broader cardiovascular kidney metabolic (CKM) framework. Materials and Methods A narrative review was conducted using PubMed, Scopus, and Web of Science. Publications available up to June 2026 were considered. The search focused on SGLT2 inhibitors, finerenone, CKD, heart failure, eGFR, albuminuria, and cardiorenal syndrome. After removal of duplicates and application of eligibility criteria, 44 publications were retained for qualitative synthesis. Results SGLT2 inhibitors primarily affect glomerular hemodynamics, natriuresis, and metabolic pathways, whereas finerenone modulates mineralocorticoid receptor mediated inflammatory and fibrotic pathways. The CONFIDENCE trial showed that simultaneous initiation of finerenone and empagliflozin produced a greater reduction in UACR than either monotherapy over 180 days. Meta analytic and observational data suggest potential additional benefits for MAKE, ESRD, some cardiovascular outcomes, and all cause mortality, although these findings vary according to comparator and study design. Hyperkalemia risk may be lower than with finerenone monotherapy but remains higher than with SGLT2 inhibitor monotherapy in some comparisons. An early decline in eGFR was observed, whereas acute kidney injury and symptomatic hypotension were uncommon. Conclusions Combined SGLT2 inhibitor and finerenone therapy is a promising option for carefully selected patients with CKD, T2D, and albuminuria. The strongest randomized evidence concerns reduction in albuminuria, whereas evidence for long term kidney and cardiovascular outcomes and mortality remains limited. Hyperkalemia risk is not eliminated, and regular monitoring of serum potassium and kidney function remains necessary. Extrapolation to the broader CKM population and to patients with heart failure requires further investigation.

  • LONG TERM DIABETES AND STRUCTURAL AND FUNCTIONAL OCULAR CHANGES BEYOND DIABETIC RETINOPATHY

    by Agata Leszek, Iga Poprawa, Michał Stermach, Nina Kubikowska, Zuzanna Gąsior, Przemysław Krukowski, Małgorzata Landowska, Anna Motybel, Zuzanna Lecyk, Małgorzata Lubowiecka

    Background Diabetes mellitus is a chronic metabolic disease associated with ocular complications beyond classical diabetic retinopathy. Long-term diabetes may affect the retinal neurovascular unit, retinal microcirculation, visual function, cornea, ocular surface, lens, optic nerve, and glaucoma-related structures. Some of these abnormalities may occur before clinically visible diabetic retinopathy. Aims The aim of this narrative review was to summarize current evidence on long-term structural and functional ocular changes associated with type 1 and type 2 diabetes mellitus, with emphasis on retinal neurodegeneration, retinal microvascular impairment, functional visual deficits, and selected extraretinal ocular complications. Methods A narrative literature review was conducted using PubMed, Embase, Cochrane Library, and Google Scholar. English-language publications from 2008 to 2026 were considered, and the final search was conducted on April 15, 2026. Search terms included diabetes mellitus, diabetic retinopathy, retinal neurodegeneration, corneal neuropathy, cataract, glaucoma, ocular complications, retina, and visual function. Meta-analyses, systematic reviews, longitudinal prospective studies, cross-sectional studies, and expert opinion articles were included. A total of 230 articles were initially identified, 85 full-text articles were assessed, and 43 key studies were included. Results Long-term diabetes was associated with retinal neurovascular damage, retinal neurodegeneration, retinal microvascular impairment, functional visual abnormalities, and selected extraretinal ocular complications. OCT studies demonstrated thinning of the inner retinal layers, including changes in the ganglion cell complex and retinal nerve fiber layer. OCT angiography may detect reduced macular microvascular density and capillary dropout before classical ophthalmoscopic signs of diabetic retinopathy. ERG, pattern ERG, VEP, and microperimetry may reveal abnormalities in retinal response, neural conduction, and macular sensitivity. Beyond the retina, diabetes was associated with corneal neuropathy, diabetic keratopathy, ocular surface disease, impaired epithelial healing, accelerated cataract formation, optic nerve and functional visual pathway involvement, and increased glaucoma risk. Conclusions Long-term type 1 and type 2 diabetes mellitus is associated with ocular changes beyond classical diabetic retinopathy. Assessment focused only on clinically visible retinopathy may miss earlier structural, microvascular, and functional abnormalities. A multimodal and individualized diagnostic approach may be useful, depending on disease duration, metabolic control, ocular symptoms, clinical findings, and available resources. Further longitudinal studies with standardized outcome measures are needed to clarify early diagnostic markers, risk stratification, and monitoring strategies for diabetes-related ocular disease.

  • Open Access

    Time is Bone: Streamlining the Diagnostic Pathway of Suspected Scaphoid Fractures with Cone-Beam CT

    by Michał Maciejowski, Mateusz Zdaniewicz, Adrian Baran, Agnieszka Olejnik, Jakub Adamiak, Bartłomiej Czyżak, Przemysław Krukowski, Zuzanna Gąsior, Agnieszka Gierlach, Anna Machowska

    Background: Scaphoid fractures present a significant diagnostic challenge in emergency departments. Conventional radiography frequently misses occult fractures, leading to either delayed diagnoses with severe complications or unnecessary, prolonged cast immobilization for healthy patients. While Magnetic Resonance Imaging (MRI) remains the gold standard, its high cost and limited availability restrict its routine use in acute settings. Cone-Beam Computed Tomography (CBCT) has emerged as a promising, accessible 3D imaging alternative. Objective: To evaluate the diagnostic accuracy of CBCT for suspected scaphoid fractures and assess its clinical utility regarding radiation dose and the optimization of the diagnostic pathway. Methods: A systematic review of PubMed, Europe PMC, and Cochrane databases was conducted up to March 2026. The review included original clinical studies providing quantitative data on the diagnostic performance of CBCT for scaphoid fractures in adult patients. Results: Six studies comprising 335 patients (106 with confirmed fractures) met the inclusion criteria. CBCT demonstrated high diagnostic validity, with sensitivity ranging from 88.9% to 100% and specificity between 96% and 100%. The median effective radiation dose (3.65–4.3 µSv) was significantly lower than that of standard multi-detector computed tomography (MDCT). Implementing early CBCT protocols reduced the median time to definitive diagnosis from 16.5 to 2.0 days, enabling 94.1% of patients to receive a conclusive diagnosis within 48 hours and reducing unnecessary fracture clinic attendances by 71.9%. Conclusions: CBCT provides diagnostic accuracy comparable to MRI with a highly favorable radiation safety profile. Integrating CBCT into routine clinical protocols for acute wrist trauma safely accelerates the diagnostic pathway, optimizes healthcare resources, and protects patients from unwarranted immobilization.

  • Benign HPV Warts of the Head and Neck: What current evidence supports for treatment

    by Iga Poprawa, Michał Stermach, Nina Kubikowska, Zuzanna Gąsior, Przemek Krukowski, Małgorzata Landowska, Agata Leszek, Anna Motybel, Wiktoria Janik, Zuzanna Lecyk

    Background Benign HPV-related warts of the head and neck are common lesions in children, adolescents, and young adults. Despite their non-malignant nature, their visibility, persistence, and recurrence result in a significant cosmetic and psychosocial burden. Management in this anatomically sensitive region requires balancing clinical effectiveness with preservation of cosmetic outcomes. Available evidence is heterogeneous and frequently not specific to the head and neck, as many studies combine different anatomical sites and lesion types. Aims To critically evaluate current treatment options for benign HPV-induced warts of the head and neck, with emphasis on the balance between clinical effectiveness and cosmetic safety, and to compare minimally invasive and destructive approaches in terms of recurrence, safety, and cosmetic outcomes. Methods A narrative review with a structured literature search was conducted using PubMed, PubMed Central, and Google Scholar. ResearchGate was used as an additional source. The search covered publications from 2015 to November 2026 and was limited to English-language studies. Eligible publications included meta-analyses, systematic reviews, randomized controlled trials, observational studies, and clinical guidelines. Study selection and data extraction were performed by two reviewers. A total of 42 studies were included in the qualitative synthesis. Results No single treatment modality was identified as universally superior. Destructive methods demonstrate high clearance rates but are associated with a higher risk of pain, scarring, pigmentary changes, and recurrence, which limits their use in cosmetically sensitive areas. Minimally invasive approaches, particularly laser-based therapies, show high effectiveness, with reported clearance rates of approximately 70 to 90 percent, and more favorable cosmetic outcomes. Intralesional immunotherapy demonstrates variable effectiveness, ranging from 23 to 95 percent, reflecting differences in agents, treatment protocols, and study populations, and may enable clearance of both treated and distant lesions with minimal risk of scarring. Topical and systemic therapies show moderate effectiveness but require prolonged treatment and high patient adherence. Evidence on HPV vaccination suggests a possible therapeutic effect, although current data remain limited and heterogeneous. Conclusions Management of benign HPV warts of the head and neck requires an individualized approach. In relation to the research questions, minimally invasive methods and immunotherapy, in selected clinical contexts, may provide a more favorable balance between effectiveness and cosmetic safety compared to destructive approaches, while destructive methods remain appropriate in selected cases. The lack of head-and-neck-specific data, heterogeneity of study designs, and limited long-term follow-up restrict the strength of conclusions and do not allow the development of standardized treatment algorithms. Further high-quality studies with standardized outcomes are required.

  • THE IMPACT OF AIR POLLUTION ON THE INCIDENCE AND PROGRESSION OF UPPER RESPIRATORY TRACT DISEASES IN URBAN POPULATIONS – NARRATIVE REVIEW

    by Michał Stermach, Nina Kubikowska, Iga Poprawa, Artur Marcysiak, Agata Leszek, Zuzanna Lecyk, Przemysław Krukowski, Zuzanna Gąsior, Paweł Mikołajczak, Aleksandra Marcysiak

    Background Air pollution remains a major environmental health factor in urban populations, with sustained exposure to particulate matter and gaseous pollutants. The upper respiratory tract is directly exposed to inhaled pollutants and represents a primary site of interaction between environmental factors and mucosal inflammation. Aims To provide a clinically oriented analysis of the association between urban air pollution and upper respiratory tract diseases, including chronic rhinosinusitis, allergic rhinitis, and acute sinusitis, with assessment of clinical outcomes, pathophysiological mechanisms, vulnerable populations, and limitations of the current evidence base. Methods A narrative review with a structured literature search was conducted using PubMed, Google Scholar, and ResearchGate. The search covered studies published between 2016 and 2025, with inclusion of selected earlier landmark studies. Eligible studies included cohort, case control, time series studies, randomized trials, as well as systematic reviews and meta analyses evaluating incidence, progression, and clinical outcomes of upper respiratory tract diseases in relation to ambient air pollution. A total of 44 studies were included in the final synthesis after screening and eligibility assessment. Results Consistent associations were identified between exposure to particulate matter and gaseous pollutants and increased incidence, symptom severity, and healthcare utilization in chronic rhinosinusitis and allergic rhinitis. Effect estimates for particulate matter were generally modest, with odds ratios around 1.2 for PM10, while nitrogen dioxide showed stronger associations in selected analyses. Short term exposure to PM2.5 and NO2 was linked to increased outpatient visits and symptom exacerbations, particularly in children. Long term exposure was more consistently associated with disease persistence and severity, including increased likelihood of surgical interventions in chronic rhinosinusitis. Evidence for acute sinusitis remains limited and heterogeneous. The main sources of variability across studies include differences in exposure assessment, diagnostic criteria, and control of confounding factors. Conclusions Urban air pollution is a clinically relevant factor associated with the burden and course of selected upper respiratory tract diseases, particularly chronic rhinosinusitis and allergic rhinitis. The strength of evidence is highest for chronic rhinosinusitis, moderate for allergic rhinitis, and limited for acute sinusitis. Current data support consideration of environmental exposure in clinical interpretation of disease dynamics, while remaining insufficient to justify direct modification of standard treatment algorithms. Further prospective and interventional studies with standardized methodology are required to clarify causal relationships and improve clinical applicability.

  • A NARRATIVE REVIEW OF THERAPEUTIC OPTIONS IN ADVANCED ENDOMETRIAL CANCER

    by Michał Stermach, Nina Kubikowska, Iga Poprawa, Artur Marcysiak, Agata Leszek, Zuzanna Lecyk, Przemysław Krukowski, Zuzanna Gąsior, Paweł Mikołajczak, Dominik Koryciński

    Background Advanced and recurrent endometrial cancer is associated with limited survival and marked clinical heterogeneity. Treatment outcomes vary according to disease extent, resectability, molecular characteristics, and patient related factors. Despite the introduction of immunotherapy and targeted approaches, uncertainty remains regarding the comparative effectiveness and clinical positioning of available treatment modalities. Aims To analyze the roles, effectiveness, and limitations of surgery, chemotherapy, radiotherapy, and immunotherapy in advanced and recurrent endometrial cancer, and to evaluate how treatment selection is determined by clinical and molecular factors. Methods This narrative review was conducted using a structured literature search in PubMed, PubMed Central, Google Scholar, Directory of Open Access Journals, and Cochrane Library. Studies published between 2010 and 2025 were considered. Eligible sources included randomized and nonrandomized clinical trials, observational studies, meta-analyses, and clinical guidelines addressing therapeutic strategies in advanced or recurrent disease. Selection was based on clinical relevance and reporting of outcomes such as overall survival, progression free survival, response rates, and treatment related toxicity. Results The available evidence demonstrates that treatment modalities are not interchangeable and provide benefit in specific clinical contexts. Cytoreductive surgery is associated with improved outcomes only when complete macroscopic resection is achievable. In unresectable or disseminated disease, systemic therapy represents the principal treatment approach. Carboplatin and paclitaxel remain the reference first line regimen due to consistent efficacy and predictable toxicity. Radiotherapy contributes to local control and symptom management but does not demonstrate consistent survival benefit in advanced disease. Immunotherapy shows substantial and durable responses in MSI H and dMMR tumors, whereas its activity in mismatch repair proficient disease is limited. Combination therapy with pembrolizumab and lenvatinib extends treatment activity to broader populations but is associated with increased toxicity. Conclusions The management of advanced endometrial cancer requires a stratified approach based on resectability, molecular profile, and patient related factors. Chemotherapy remains the central systemic component in unselected populations, while immunotherapy provides clinically meaningful benefit in molecularly defined subgroups. No single therapeutic strategy demonstrates consistent superiority across all patients. Interpretation of available data is limited by heterogeneity of study designs and incomplete representation of real world populations. Optimal sequencing and integration of treatment modalities remain insufficiently defined and require further investigation in prospective studies with molecular stratification.

  • NIGHT AND SHIFT WORK – A REVIEW OF THE IMPACT ON PHYSICAL AND MENTAL HEALTH

    by Patryk Krawczak, Marta Kwiatkowska, Michał Stermach, Nina Kubikowska, Małgorzata Landowska, Iga Poprawa, Zuzanna Gąsior, Przemysław Krukowski, Artur Marcysiak

    Background Shift and night work are essential for the functioning of modern societies but are associated with significant disruption of the circadian rhythm. This disruption has been linked to a wide range of adverse health outcomes affecting mental, physical, and endocrine function. Despite growing evidence, the multidomain consequences of shift work remain insufficiently recognized in clinical and occupational practice, and no integrative synthesis has yet examined these effects with particular emphasis on healthcare professionals. Aims This review aimed to provide a comprehensive and updated synthesis of the adverse health effects of night and shift work, to identify specific risk domains, and to summarize evidence-based preventive strategies applicable in occupational settings. Methods A narrative review of the literature was conducted using PubMed, Google Scholar, and ResearchGate. Publications from 2010 to 2026 were included. Eligible study types comprised meta-analyses, systematic reviews, cohort studies, and case-control studies reporting on health outcomes associated with night or shift work schedules. Results Shift workers demonstrate significantly higher rates of depression, anxiety, suicidal ideation, and cognitive decline. Approximately 30% develop shift work disorder. Cardiometabolic consequences include hypertension, cardiovascular events, obesity, dyslipidemia, type 2 diabetes, and metabolic syndrome. Endocrine disruptions affect melatonin, cortisol, thyroid, and sex hormones, contributing to menstrual irregularities, earlier menopause, and increased miscarriage risk. Conclusions Shift work exerts substantial multidomain negative effects on health. Targeted preventive interventions, including light therapy, structured sleep and meal schedules, and psychological support, are warranted, particularly in healthcare professionals and other vulnerable populations.

  • Open Access

    The Characteristic of Injuries Among Combat Sport Athletes in Particular Disciplines

    by Mateusz Zdaniewicz, Agnieszka Olejnik, Jakub Adamiak, Michał Maciejowski, Bartłomiej Czyżak, Adrian Baran, Justyna Jankowska, Zuzanna Gąsior, Przemysław Andrzej Krukowski, Jan Szadkowski

    Background. The frequency of related injuries is growing. Traumas affect people of all ages, both professionals and amateurs. However, they vary and their characteristics differ significantly depending on the discipline. Aim. The objective of the present study was to elucidate the variability in injury patterns across different combat sports to improve athletes’ safety and contributing to the mitigation of injury risk in combat sports, Material and methods. We analyzed over 40 scientific articles contained in the PubMed database. We related the collected data to parameters such as specific discipline, gender, age, injury mechanism, location, and, in some cases, required treatment and presented the results in the form of paragraphs. Results. In Taekwon-do and Judo injuries mostly occurred in lower limbs. mainly in knees. In karate mostly refer to foot and ankle. Hands were mostly injured in Boxing. MMA competitors mostly experienced wrists and hands traumas. Head injuries occurred most often in Boxing, Kickboxing, Karate, MMA. Many of those traumas were connected with neck injuries. In TKD there were mainly joint sprains or dislocations. Soft tissue contusion was the most common in boxing. Most common in kickboxing were lacerations and fractures. In Karate mostly occurred contusions and lacerations. MMA injuries were mostly: lacerations/abrasions, fractures, nerve injuries. Conclusions. Injuries in combat sports are a very broad and diverse issue. Particulars disciplines show many similarities in this regard, but also differ significantly in terms of specific parameters. The characteristics of injuries in combat sports should be carefully analyzed based on a division into disciplines which may increase the safety of athletes.

  • Gel Manicure and Associated Risks - narrative review

    by Michał Stermach, Nina Kubikowska, Iga Poprawa, Zuzanna Gąsior, Przemek Krukowski, Małgorzata Landowska, Marta Kwiatkowska, Patryk Krawczak, Artur Marcysiak

    Background Gel manicure is widely used in professional and home settings. Concerns relate to chemical exposure from acrylate containing nail products, ultraviolet radiation emitted by nail curing lamps, occupational exposure among nail technicians, and potential microbiological implications. Aims To systematize published evidence on health effects associated with gel manicure use, with emphasis on allergic reactions, ultraviolet exposure related outcomes, occupational risks, and microbiological findings, and to identify gaps in the current evidence base. Methods A narrative review was conducted using PubMed, Google Scholar, and ResearchGate. Publications from January 2010 to March 2025 were considered. Only English language articles were included. Inclusion criteria comprised randomized controlled trials, cohort studies, case control studies, systematic reviews, meta analyses, and international or national guidelines reporting health effects or exposure characteristics related to gel manicure use. Exclusion criteria included single case reports, conference abstracts, non peer reviewed publications, animal studies, and articles lacking explicit data on gel manicure exposure or associated health outcomes. The initial search yielded 223 records, and 44 publications were retained for analysis. Results Nail curing devices predominantly emit UVA radiation with peak wavelengths between 365 and 405 nm, with substantial variability across lamp types and designs. Under typical usage conditions, cumulative ultraviolet exposure during manicure sessions remains below levels associated with clinically significant dermatologic damage or increased skin cancer risk. Allergic contact dermatitis related to acrylate and methacrylate containing products is the most frequently reported adverse outcome, particularly among nail technicians and younger users. Evidence on microbial retention and reduced hand hygiene effectiveness with gel or artificial nails is heterogeneous and context dependent. Conclusions Available evidence indicates that allergic sensitization to acrylate containing nail products represents the primary clinically relevant health risk of gel manicure, whereas ultraviolet radiation related carcinogenic risk appears minimal under typical use. Standardization of exposure assessment and further research on occupational and microbiological outcomes are needed.

  • The Role of Semaglutide in Obesity Treatment: Effectiveness and Safety Based on Current Evidence

    by Zuzanna Gąsior, Przemysław Krukowski, Michał Stermach, Nina Kubikowska, Iga Poprawa, Małgorzata Landowska, Marta Kwiatkowska, Patryk Krawczak, Michał Maciejowski, Mateusz Zdaniewicz

    Background Obesity is a chronic disease associated with increased cardiometabolic risk and requires long term multidisciplinary management. Semaglutide, a glucagon like peptide 1 receptor agonist, has emerged as an effective pharmacological option for weight management. The aim of this narrative review is to analyze current clinical evidence on the efficacy, safety, and adverse event profile of semaglutide in adults with overweight or obesity. Methods A narrative review of publications indexed in PubMed, Scopus, Web of Science, Embase, Google Scholar, and ResearchGate was conducted. Eligible studies published between 2020 and 2026 included randomized controlled trials, cohort studies, systematic reviews, meta analyses, and international clinical guidelines. Only studies involving adult participants meeting established indications for pharmacological obesity treatment, defined as a body mass index of at least 30 kg per square meter or at least 27 kg per square meter with weight related comorbidities, were included. Results The review synthesizes evidence from the STEP 1 to 8 clinical trials evaluating once weekly subcutaneous semaglutide in diverse clinical and ethnic populations. Across all trials, semaglutide in combination with lifestyle modification was consistently associated with clinically meaningful weight reduction compared with placebo. Comparative data demonstrate greater weight loss with semaglutide than with liraglutide in adults without diabetes mellitus. Semaglutide was effective in Asian populations characterized by increased cardiometabolic risk at lower body mass index values and was associated with reductions in visceral adipose tissue. In individuals with type 2 diabetes mellitus, weight loss was less pronounced but remained clinically relevant. The most frequently reported adverse events were gastrointestinal in nature and were predominantly mild to moderate in severity, with low rates of serious adverse events and treatment discontinuation. Conclusions Current clinical evidence indicates that once weekly subcutaneous semaglutide, used as an adjunct to lifestyle intervention, is an effective and generally well tolerated pharmacological option for weight management in adults with overweight or obesity. Maintenance of weight reduction requires continued treatment, supporting the concept of obesity as a chronic condition requiring long term therapeutic strategies.